4//SEC Filing
Nayak Asha 4
Accession 0001562180-19-003394
CIK 0001597553other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:02 PM ET
Size
7.8 KB
Accession
0001562180-19-003394
Insider Transaction Report
Form 4
Nayak Asha
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-05+10,000→ 10,000 totalExercise: $177.41Exp: 2029-06-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 5, 2020 or the day immediately prior to the 2020 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001722119
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:02 PM ET
- Size
- 7.8 KB